-+ 0.00%
-+ 0.00%
-+ 0.00%

J&J: MOST TREATMENT-RELATED ADVERSE EVENTS WERE MILD TO MODERATE IN ADVANCED PROSTATE CANCER STUDY

Reuters·10/24/2026 08:15:00

Please log in to view news